Pharsight

Aucta patents expiration

1. Motpoly Xr patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11337943 AUCTA Lacosamide pharmaceutical composition and dosage form thereof
Jun, 2040

(16 years from now)

Drugs and Companies using LACOSAMIDE ingredient

Market Authorisation Date: 04 May, 2023

Treatment: Treatment of partial-onset seizures in adults and in pediatric patients weighing at least 50 kg

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

MOTPOLY XR family patents

Family Patents